Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Elias Schweig

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Neuroscience Letters|April 26, 2020
Neuronal Spleen tyrosine kinase (SYK) mediates cytokine release in Transgenic Tau P301S mice organotypic brain slice culturesJonas Elias Schweig, Hailan Yao, Chao Jin, et al.
Frontiers in Cellular Neuroscience|October 26, 2019
Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic ActivitiesHailan Yao, Kyle Coppola, Jonas Elias Schweig, et al.
The Journal of Biological Chemistry|July 21, 2019
Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation <i>in vitro</i> and <i>in vivo</i>Jonas Elias Schweig, Hailan Yao, Kyle Coppola, et al.
Acta Neuropathologica Communications|September 8, 2017
Alzheimer's disease pathological lesions activate the spleen tyrosine kinaseJonas Elias Schweig, Hailan Yao, David Beaulieu-Abdelahad, et al.
BMC Neuroscience|May 26, 2021
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's diseaseCharis Ringland, Jonas Elias Schweig, Maxwell Eisenbaum, et al.
Neurobiology of Aging|August 8, 2020
Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's diseaseCharis Ringland, Jonas Elias Schweig, Daniel Paris, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Neuroscience Letters|April 26, 2020
Neuronal Spleen tyrosine kinase (SYK) mediates cytokine release in Transgenic Tau P301S mice organotypic brain slice culturesJonas Elias Schweig, Hailan Yao, Chao Jin, et al.
Frontiers in Cellular Neuroscience|October 26, 2019
Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic ActivitiesHailan Yao, Kyle Coppola, Jonas Elias Schweig, et al.
The Journal of Biological Chemistry|July 21, 2019
Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation <i>in vitro</i> and <i>in vivo</i>Jonas Elias Schweig, Hailan Yao, Kyle Coppola, et al.
Acta Neuropathologica Communications|September 8, 2017
Alzheimer's disease pathological lesions activate the spleen tyrosine kinaseJonas Elias Schweig, Hailan Yao, David Beaulieu-Abdelahad, et al.
BMC Neuroscience|May 26, 2021
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's diseaseCharis Ringland, Jonas Elias Schweig, Maxwell Eisenbaum, et al.
Neurobiology of Aging|August 8, 2020
Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's diseaseCharis Ringland, Jonas Elias Schweig, Daniel Paris, et al.
Pageof 1